Advertisement

ADVERTISEMENT

pancreatic cancer

News
Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay`s MRIdian Linac
08/13/2020

ViewRay, Inc

ViewRay, Inc
CLEVELAND, Aug. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian® MRI-Guided Therapy...
CLEVELAND, Aug. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian® MRI-Guided Therapy...
CLEVELAND, Aug. 13,...
08/13/2020
IO Learning
A Novel Dual-Balloon Catheter for the Treatment of Locally Advanced Pancreatic Cancer
Interview
A Novel Dual-Balloon Catheter for the Treatment of Locally Advanced Pancreatic Cancer
06/08/2020

Ripal T. Gandhi, MD, FSIR, FSVM

Ripal T. Gandhi, MD, FSIR, FSVM ...
IO Learning invited Dr Gandhi to discuss his 2020 Society of Interventional Radiology (SIR) abstract, “Overcoming Limitations in the Treatment of Locally Advanced Pancreatic Cancer With Transarterial Microperfusion Utilizing a Novel...
IO Learning invited Dr Gandhi to discuss his 2020 Society of Interventional Radiology (SIR) abstract, “Overcoming Limitations in the Treatment of Locally Advanced Pancreatic Cancer With Transarterial Microperfusion Utilizing a Novel...
IO Learning invited Dr Gandhi to...
06/08/2020
IO Learning
News
Anti-CEA CAR-T Demonstrates Significant Therapeutic Effect in Pancreatic Cancer Patients With Liver Metastases
11/07/2018
A concentrated dose of anti-CEA CAR-T cells administered precisely at the site of a solid tumor by Pressure-enabled Drug Delivery (PEDD) (TriSalus Life Sciences’) is safe, with encouraging clinical responses, according to the results of a...
A concentrated dose of anti-CEA CAR-T cells administered precisely at the site of a solid tumor by Pressure-enabled Drug Delivery (PEDD) (TriSalus Life Sciences’) is safe, with encouraging clinical responses, according to the results of a...
A concentrated dose of anti-CEA...
11/07/2018
IO Learning
Blood Test Predicts Treatment Response for NETs
06/27/2016
JCP Editors
A study presented at the 2016 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (June 11-15; San Diego, CA [SNMMI]) has found that a novel investigative blood test could predict how patients with...
A study presented at the 2016 Society of Nuclear Medicine and Molecular Imaging Annual Meeting (June 11-15; San Diego, CA [SNMMI]) has found that a novel investigative blood test could predict how patients with...
A...
06/27/2016
Journal of Clinical Pathways
Research in Review
Pancreatic Cancer Resources Available Online Inaccurate and Difficult to Read
05/13/2016
JCP Editors
Online materials about pancreatic cancer may lack accurate information about alternative therapy and be too complicated to benefit patients with the disease, claims a recent study. The readability and accuracy of...
Online materials about pancreatic cancer may lack accurate information about alternative therapy and be too complicated to benefit patients with the disease, claims a recent study. The readability and accuracy of...
Online...
05/13/2016
Journal of Clinical Pathways
Research in Review
Chemoradiotherapy Does Not Improve Survival for Patients With Pancreatic Cancer
05/11/2016
JCP Editors
Adding radiation to chemotherapy regimens may not improve overall survival compared with chemotherapy alone in patients with locally advanced pancreatic cancer, according to results from a clinical trial. The trial,...
Adding radiation to chemotherapy regimens may not improve overall survival compared with chemotherapy alone in patients with locally advanced pancreatic cancer, according to results from a clinical trial. The trial,...
Adding...
05/11/2016
Journal of Clinical Pathways
TGFβ Pathway Inhibitor Improves Survival in Patients With Pancreatic Cancer
04/22/2016
JCP Editors
Galunisertib plus gemcitabine may improve overall survival and progression-free survival compared to gemcitabine alone in patients with pancreatic cancer, according to a study presented at the American Association...
Galunisertib plus gemcitabine may improve overall survival and progression-free survival compared to gemcitabine alone in patients with pancreatic cancer, according to a study presented at the American Association...
...
04/22/2016
Journal of Clinical Pathways
Research in Review
Pancreatic Cancer May Actually Be Four Distinct Diseases
03/03/2016
JCP Editors
Pancreatic cancer may actually present as four separate diseases, according to a recently published study from the United Kingdom. Prognoses for patients with pancreatic cancer are generally poor because a limited...
Pancreatic cancer may actually present as four separate diseases, according to a recently published study from the United Kingdom. Prognoses for patients with pancreatic cancer are generally poor because a limited...
...
03/03/2016
Journal of Clinical Pathways
Clinical Insights
The CROSSFIRE Study of Irreversible Electroporation for Pancreatic Cancer: Can IRE Improve Survival?
12/27/2015

Laurien Vroomen, MD1; Hester Scheffer, MD1; Govindarajan Narayanan, MD2; Martijn Meijerink, MD, PhD1

 

From the 1VU University Medical Center, Amsterdam, the Netherlands, and the 2Miami Miller School of Medicine, Miami, Florida, USA.

Laurien Vroomen, MD1; Hester Scheffer...
Irreversible electroporation (IRE) is a promising new ablation technique to fight pancreatic cancer. Cell death is achieved by delivering high-voltage pulses. The CROSSFIRE trial is an international phase 3, multicenter, randomized controlled...
Irreversible electroporation (IRE) is a promising new ablation technique to fight pancreatic cancer. Cell death is achieved by delivering high-voltage pulses. The CROSSFIRE trial is an international phase 3, multicenter, randomized controlled...
Irreversible electroporation...
12/27/2015
IO Learning
Interview
Advances and Trends in Interventional Therapies for Pancreatic and Liver Cancer Discussed at Synergy 2015
11/07/2015
By Jennifer FordOn November 6, 2015, the second day of the 2015 Synergy interventional oncology meeting in Miami began with a hands-on ablation workshop. The workshop was packed with attendees, many of whom were residents and fellows who...
By Jennifer FordOn November 6, 2015, the second day of the 2015 Synergy interventional oncology meeting in Miami began with a hands-on ablation workshop. The workshop was packed with attendees, many of whom were residents and fellows who...
By Jennifer FordOn November 6,...
11/07/2015
IO Learning

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use